Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 23, 2025
Management of gastrointestinal bleeding in a patient with type 3 von Willebrand disease and inhibitors to von Willebrand factor: a case reportEna Ranković, Marijo Vodanović, Marino Narančić, et al.
Diagnostics (Basel, Switzerland)|December 23, 2022
Individualized Management of Coagulopathy in Patients with End-Stage Liver DiseaseTina Tomić Mahečić, Robert Baronica, Anna Mrzljak, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 11, 2023
Accreditation model of European Haemophilia Centres in the era of novel treatments and gene therapyAna Boban, Fariba Baghaei, Fijnvandraat Karin, et al.
Food Research International (Ottawa, Ont.)|February 23, 2024
Spontaneous fermentation of Maraština wines: The correlation between autochthonous mycobiota and phenolic compoundsAna Boban, Vesna Milanović, Maja Veršić Bratinčević, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 24, 2025
Physical Activity Awareness and Understanding of Treatment Protection Among People With Haemophilia and Their Caregivers in Central EuropeAngelika Batorova, Atanas Banchev, Ana Boban, et al.
Advances in Therapy|April 18, 2023
Complement Inhibition in Paroxysmal Nocturnal Hemoglobinuria (PNH): A Systematic Review and Expert Opinion from Central Europe on Special Patient PopulationsImre Bodó, Ismail Amine, Ana Boban, et al.
Food Research International (Ottawa, Ont.)|December 3, 2022
Croatian white grape variety Maraština: First taste of its indigenous mycobiotaVesna Milanović, Federica Cardinali, Ilario Ferrocino, et al.
The Pediatric Infectious Disease Journal|November 19, 2019
Cytomegalovirus Seroprevalence and Birth Prevalence of Congenital CMV Infection in Bosnia and Herzegovina: A Single-Center ExperienceJurica Arapović, Borko Rajič, Sunil Pati, et al.
European Journal of Haematology|January 30, 2026
Efficacy and Safety of Prophylaxis With a Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (Wilate) in Patients With Type 3 von Willebrand Disease-A WIL-31 Study Sub-AnalysisClaudia Djambas Khayat, Leonid Dubey, Adlette Inati, et al.
Advances in Therapy|May 16, 2024
florio<sup>®</sup> HAEMO: A Longitudinal Survey of Patient Preference, Adherence and Wearable Functionality in Central EuropeEster Zapotocka, Angelika Batorova, Ernest Bilic, et al.
Pageof 5